Johns Hopkins ABX Guide
Artemether/Lemefantrine
Artemether/Lemefantrine is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients with ≥ 5 kg.
- Manufacturer does not recommend use for the treatment of severe malaria or the prevention of P. falciparum malaria.
- Most recent CDC guidelines recommend artemether/lumefantrine use for the treatment of severe malaria following administration of IV artesunate or while waiting for IV artesunate to arrive from CDC (see CDC website)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of severe malaria due to P. falciparum following administration of IV artesunate or while awaiting for IV artesunate to arrive from CDC.
- Treatment of uncomplicated P. vivax malaria (2015 WHO recommendations)[2].
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of acute, uncomplicated malaria infections due to Plasmodium falciparum in patients with ≥ 5 kg.
- Manufacturer does not recommend use for the treatment of severe malaria or the prevention of P. falciparum malaria.
- Most recent CDC guidelines recommend artemether/lumefantrine use for the treatment of severe malaria following administration of IV artesunate or while waiting for IV artesunate to arrive from CDC (see CDC website)
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of severe malaria due to P. falciparum following administration of IV artesunate or while awaiting for IV artesunate to arrive from CDC.
- Treatment of uncomplicated P. vivax malaria (2015 WHO recommendations)[2].
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: June 6, 2019
Citation
Avdic, Edina. "Artemether/Lemefantrine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540604/0.1/Artemether_Lemefantrine.
Avdic E. Artemether/Lemefantrine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540604/0.1/Artemether_Lemefantrine. Accessed January 31, 2023.
Avdic, E. (2019). Artemether/Lemefantrine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540604/0.1/Artemether_Lemefantrine
Avdic E. Artemether/Lemefantrine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2023 January 31]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540604/0.1/Artemether_Lemefantrine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Artemether/Lemefantrine
ID - 540604
A1 - Avdic,Edina,Pharm.D.
Y1 - 2019/06/06/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540604/0.1/Artemether_Lemefantrine
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine
ER -
